Ligand validation:4UH1

EXI: N1-(5-(2-(6-Amino-4-methylpyridin-2-yl)ethyl)pyridin-3-yl)-N1,N2-dimethylethane-1,2-diamine

EXI is a Ligand Of Interest in 4UH1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UH1_EXI_B_800	54%	17%	0.142	0.906	1.19	2.42	2	7	1	0	100%	1
4UH1_EXI_A_800	29%	20%	0.217	0.878	1.04	2.3	3	11	2	0	100%	1
4UH5_EXI_B_800	64%	37%	0.155	0.955	0.36	2.08	-	9	2	0	100%	1
5G0N_EXI_B_800	38%	43%	0.233	0.938	0.43	1.75	-	7	2	0	100%	1
4UH8_EXI_B_800	67%	40%	0.142	0.949	0.41	1.9	-	9	1	0	100%	1
4UGY_EXI_A_904	42%	4%	0.158	0.878	2.1	3.73	3	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.